Erratum for Rockall et al., J Clin Oncol 23 (12) 2813-2821.

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?

ERRATUM

The specific investigational drug (generic name: ferumoxtran-10; trade names: Combidex® in the US, Sinerem® in Europe) used in this clinical trial was frequently called by the acronym USPIO (ultrasmall superparamagnetic iron oxide), a chemical class name. Ferumoxtran-10 should have been used consistently to refer to the results obtained with this specific drug. The generic name should have been used in the discussion, except where the statements being made are known to be true for the entire class of contrast agents.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This Article Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Social Bookmarking                            What's this?